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Abstract 
Purpose: To evaluate toxicological risks for workers who are exposed to lead in their work environment.  
Methods: Since it is an important indicator of toxicological risk, a statistical analysis of lead 
concentration and biological lead toxicity markers in blood and urine were performed for both exposed 
and control groups. Both experimental groups consisted of employees from "NISSAL" JSC factory. 
Analytical epidemiological method in the form of a retrospective cohort study was applied, and covered 
the period from 2001 to 2010. The concentration of lead, δ-aminolevulinic acid, and coproporphyrin in 
biological samples were determined by spectrophotometric methods. 
Results: The results showed a high positive correlation between lead concentrations in blood and urine 
and the length of exposure of the participants (p < 0.01). Also, increase of lead concentration in the 
biological material significantly increased δ-aminolevulinic acid (p < 0.01) and slightly increased the 
concentration of coproporphyrin, both of which are important indicators of toxicological risk. 
Conclusion: The control group of employees belonged to the normal risk category, while the exposed 
group belonged to a moderate risk category. Correlation between the monitored parameters is 
statistically significant at p < 0.01 and p < 0.05. 
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 Lead as a highly toxic, non-essential metal with 
a cumulative effect in humans, represents a 
serious environmental and health issue. People 
can experience lead poisoning from various 
sources: contaminated air, food, water, work 
environment, etc [1]. After entering the human 
body, lead is transported through the blood 
system to the target organs (liver, kidneys, brain, 
or bones) where it manifests its toxic effects due 
to its high affinity for binding with donor atoms of 
functional groups from different biomolecules 
(enzymes) [2]. Lead values in the blood are the 
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most common bioindicator of direct exposure to 
this toxic metal, which causes significant 
disorders in blood parameters [3,4]. After 
interacting with enzymes, lead inhibits their 
activity, and due to this inhibition, the values of δ-
aminolevulinic acid (synthetase and 
dehydratase), coproporphyrin, and 
protoporphyrin in erythrocytes, plasma and urine 
are increased [5]. Lead is eliminated from the 
body mostly through the urinary system, and 
partly through the gastrointestinal tract [6]. 
 
According to the American Center for Disease 
Control (ACDC) [7], blood lead level of less than 
0.98 µmol/dm3 (µM further in the manuscript) is 
considered normal, 1.21 to 2.37 µM belongs to 
the moderate risk category, 2.41 to 3.33 µM to 
the high-risk category, while the amounts higher 
than 3.38 µM fall into the urgent risk category. 
Nevertheless, the prolonged exposure to low-
level toxicity (<1.16 µM) can lead to various 
psychological disorders and learning disabilities 
among children. Naturally, these symptoms can 
occur among children even in the case of lead 
intake in amounts less than 0.24 µM. The 
allowed blood lead levels in some industrialized 
countries are shown in Table 1. 
 







[8] USA 0.13 
Poland 0.13 
Thailand 0.15 [9] 
Germany 0.17 [10] 
Italy 0.22 [11] 
United Kingdom 1.45 [12] Australia 2.41 
 
The aim of the present study is to evaluate 
toxicological risks for the workers who are 
exposed to lead in their work environment 
(NISSAL factory, Niš, Serbia; hereinafter 
"Nissal"). The values of this toxic metal and the 
biological markers (δ-aminolevulinic acid and 
coproporphyrin) in the blood and urine were 




The study was carried out by monitoring the 
values of lead and biological markers in the 
blood and urine in groups of employees (the 
exposed and the control group) in "Nissal", in the 
period from 2001 to 2010. All the employees in 
the exposed group (871 individuals) were male, 
with the average age of 45.4, and all of them had 
been employed at least one year in the metal 
processing industry. The employees in the 
control group (60 individuals) were also 
exclusively male, with the average age of 44.1, 
and all of them were office employees, protected 
from lead exposure. 
 
Analyses were made according the approvals at 
the Institute of Employees Health Care, Niš (no. 
01-01/2011); Institute of Public Health, Niš (no. 
9-25/2011); and Military Medical Academy in 
Belgrade (no. 3473-1/2010), all of this in 
accordance with international guidelines for 
animal/human studies [13]. Lead level values in 
the examined biological samples were 
determined by Atomic Absorption Spectrometry 
(AAS) and Graphite Furnace Atomic Absorption 
Spectrometry (GFAAS). Coproporphyrin (CP) 
and δ-aminolevulinic (δ-ALA) acid values were 
determined by UV-VIS spectrophotometry 




All results are presented as average values of all 
samples from each group (mean ± standard 
deviation), and statistics evaluated by Students’ 
t-test (independent sample), linear regression, 
and correlation analysis. Statistical significance 




The values of the investigated parameters for 
both the exposed and the control group of 
employees which include results of tests of lead 
levels in the blood and urine, as well as 
coproporphyrin and δ-aminolevulinic acid 





Figure 1: Levels of Pb in blood and urine, and δ-ALA 
and CP levels in urine 
 




Figure 2: Some specific values of Pb in (a) blood and (b) urine; as well as of (c) δ-ALA and (d) CP in the urine for 
exposed and control groups 
 
An overview of the monitored parameters, such 
as minimum and maximum values, the mode 
values, and the allowed normal values for each 
parameter in exposed and control groups are 
shown in Figure 2. 
 
The blood lead level was 1.39 µM for the 
exposed group and 0.32 µM for the control group 
of employees (Figure 1). The mode values were 
1.43 µM for the exposed group and 0.15 µM for 
the control group, while the maximum value in 
the exposed group was 2.43 µM, and 1.40 µM in 
the control group (Figure 2a). Experimental data 
for blood lead levels were within the allowed 
range for this metal. 
 
The mean value of urine lead level was 0.20 µM 
for the exposed employees, and 0.08 µM for the 
control group (Figure 1). Figure 2b shows that 
the maximum value for urine lead level for the 
exposed group (0.59 µM) was higher than the 
allowed value (0.576 µM), which makes lead in 
the urine an important parameter to be 
considered. 
  
Data from Figures 1 and 2c show that the values 
of δ-ALA for the control (4.90 µM) and the 
exposed (43.7 µM) group were lower than the 
allowed values of this parameter in the urine 
(76.3 µM). The mode value of δ-ALA in the 
exposed group was 48.3 μM (Figure 2c), which is 
slightly higher than the mean value. The 
maximum value of this parameter determined in 
the exposed group was 111.9 μM (at cca. 80 
employees), which is higher than the mean value 
and the allowed value (76.3 μM) of δ-ALA in the 
urine. 
 
The value of coproporphyrin was 0.03 µM for the 
control group, and 0.12 µM for the exposed 
group (Figure 1). Coproporphyrin concentration 
from the exposed group was close to the mode 
value (0.13 µM), and both were lower than the 
allowed value (0.18 µM), Figure 2d. This 
parameter was characterized by the maximum 
value (0.27 µM) which is higher than the normal 
mean value and the allowed values. 
 




Figure 3: Dependence between the length of exposure and lead levels in (a) blood and (b) urine 
 
The relationship between the influence of the 
period of lead exposure and values of the 
monitored parameters in the blood and urine was 
evaluated using the Pearson's correlation 
coefficient (Table 2). 
 











r 0.854** 0.722** 0.767** 0.843** 
   r = correlation coefficient; **p < 0.01 
 
According to the data in Table 2 (r > 0.70 for Pb 
and δ-ALA in the urine, as well as Pb in the blood 
and CP in the urine) there is a high positive 
correlation between the evaluated biological 
parameters and length of exposure, with 
statistical significance at p < 0.01. 
 
The dependence between the length of exposure 
and the concentration of the measured 
parameters in the biological material of the 
exposed group was evaluated using the 
MATLAB software. Figure 3 shows the 
dependence between length of exposure and 
lead levels in the blood (Figure 3a) and urine 
(Figure 3b), while in Figure 4 the dependence 
data for δ-ALA (Figure 4a) and CP (Figure 4b) in 
the urine are shown. The obtained data show a 
linear dependence, and considering the higher 
order polynomial interpolation, have the smallest 
margin of error within the range observed. 
 
Correlation data concerning the relationship 
between lead levels in the blood and urine, and 
values of δ-ALA in the urine are presented in 
Table 3. 
 
Table 3: Correlation between lead and δ-ALA 
concentration 
 
 Pb (blood) Pb (urine) 
r 0.766** 0.703** 
r = correlation coefficient; **p < 0.01 
 
 




Figure 4: Correlation between length of exposure, and (a) δ-ALA and (b) CP in urine 
 
According to the data (Table 3), there is a 
statistically significant (p < 0.01) positive 
correlation between lead levels in the blood and 
urine, as well as δ-ALA concentration in the 
urine. Therefore, a higher concentration of lead 
in the blood and urine causes a higher 
concentration of δ-aminolevulinic acid in the 
urine (Figure 5). 
 
Correlation data related to the relationship 
between lead concentration in the blood and 
urine, and values of CP in the urine are 
presented in Table 4. 
 
Table 4: Correlation between lead concentration 
in the blood and urine, and values of CP in the 
urine 
 
 Pb (blood) Pb (urine) 
r 0.765** 0.688** 
   r = correlation coefficient; **p < 0.01 
 
There is a statistically significant positive 
correlation between the concentration of lead in 
the blood and urine, and the concentration of 
coproporphyrin in the urine of the exposed group 
(Figure 5). Higher concentrations of lead in the 
blood and urine cause higher concentrations of 
coproporphyrin in the blood. The recorded 
correlation is relatively high and statistically 





Blood lead level is the most appropriate indicator 
of real, current, or previous continuous exposure 
to this toxic metal [3,4]. Even with low 
concentrations in the blood lead has neurotoxic 
effects, as well as a vasoconstrictive effect; 
therefore, it can have nephrotoxic effects and 
influence on the activity of some enzymes and 
values of blood parameters [2,16,17]. Blood lead 
levels of the exposed and control group are cca. 
50 % and cca. 90 % (respectively) lower than the 
allowed value (Figure 1). The maximum value for 
the exposed group is cca. 15 % lower, and for 
the control group is cca. 50 % lower than the 
allowed value (Figure 2). The difference between 
the control and the exposed group (1.07 μM) is 
statistically significant at p < 0.05. 
 
The data obtained in this study for the control 
and exposed group are higher than the allowed 
lead values in some industrialized countries 
(Table 1). According to the literature data, a 
longer period of exposure to low toxicity levels (< 
1.16 µM) can cause various psychological 
conditions and learning disabilities in children [6]. 
Lead concentrations higher than 0.39 µM have  




Figure 5: Dependence between CP and lead concentration in the blood (a) and urine (b) 
 
less influence on the cardiovascular system [18], 
while concentrations lower than 1.93 µM have 
adverse effects on the urinary system [19]. 
ACDC considers concentrations lower than 1.16 
μM as normal, and concentrations of 1.21-2.37 
µM as moderate risk concentrations [6]. Based 
on these facts and the results obtained in this 
study, the control group of employees belongs to 
a normal risk category, while the exposed group 
of employees belongs to a moderate risk 
category. 
 
The mean values of lead in the urine for the 
control and the exposed groups are cca. 85 % 
and cca. 65 % lower than the allowed values for 
this metal in the urine. However, in some of the 
employees’ urine samples maximum lead levels 
were found, cca. 2.5 % higher than the allowed 
value. Also, the obtained results indicate lower 
lead levels in the urine than in the blood, cca. 
85% lower for the exposed group and cca. 75 % 
for the control group. The difference between the 
control and the exposed group (0.12 µM) is 
statistically significant at p < 0.05. Blood lead 
levels are a better indicator of exposure than 
lead concentration in the urine, because the 
concentration in the urine depends on the 
specific weight and diuresis [20]. Data from the 
literature show that exposure to inorganic lead 
causes increased levels of metals in the urine, 
around 10 % of the blood intake [21]. 
 
Due to the fact that lead inhibits three enzymes 
in the biosynthesis of heme (δ-ALA, 
coproporfirinogen oxidase and ferrochelatase) 
and its effects on the dehydratase of δ-ALA are 
the greatest, the level of δ-ALA in the urine is 
increased, and represents the most sensitive 
indicator of lead toxicity [22].  
 
The obtained values for δ-ALA are lower than the 
allowed value for this parameter in the urine – 
cca. 40 % for the exposed group, and cca. 90 % 
for the control group. Coproporphyrin values in 
the urine show a similar tendency. Maximum 
values for these two biological indicators which 
were found in the exposed group are cca. 30 % 
higher than the allowed values. Differential 
values between the control and the exposed 
group for both indicators are statistically 
significant at p < 0.05. Analysis of the 
dependence between lead levels in the blood 
Krstic et al 
2965 
 
and urine, and the concentration of δ-ALA in the 
exposed group showed a statistically significant 
positive correlation at p < 0.01, which is in 
accordance with the results of Barbarossa et al 
[4]. Also, a group of authors found that the 
increased excretion of δ-ALA begins at blood 
lead levels from 1.45 to 1.93 µM, while it is most 
pronounced at a level between 2.41 and 2.89 
µM; the increased excretion of coproporphyrin 
occurs at blood lead levels between 1.69 and 
1.93 µM [23], similar to the results from our 
study. The concentration of coproporphyrin in the 
urine showed high sensitivity (97.8 %) at the 
recorded blood lead level of 2.89 µM. The 
analysis of the dependence of lead values in the 
blood and urine, and coproporphyrin 
concentration in the exposed group showed a 
statistically significant positive correlation at p < 
0.01. 
 
According to McElvaine et al, the increased 
levels of coproporphyrin occur when blood lead 
level is 1.93 µM [24], which was confirmed by the 
results obtained in this research. The obtained 
results confirmed a high positive correlation 
between the concentration of lead in the blood 
and urine, and years of service of the exposed 
subjects (r = 0.854, p < 0.01, and r = 0.722, p < 
0.01, respectively). Lee et al found a high 
positive correlation between blood lead levels 
and years of service [25], which complies with 
the results obtained in the present research. 
 
By analyzing the connection between δ-ALA acid 
and CP, and years of service of exposed 
subjects in both technological systems, which is 
again closely related to the connection between 
lead levels and years of service, a high positive 
correlation was identified, which indicates the 




The findings of the present study show that the 
control group of employees belongs to a normal 
risk category, while the exposed group belongs 
to a moderate risk category. The difference 
between the mean values of lead concentrations 
in the blood and urine in the exposed group and 
the control group was statistically significant at p 
< 0.05. Analysis of the dependence between 
lead levels in blood and urine, and the 
concentration of δ-ALA, such as CP in the 
exposed group, showed a statistically significant 
positive correlation at p < 0.01. High positive 
correlation (p < 0.01) between the concentration 
of lead in the blood and urine, and the years of 
service of the exposed subjects was also 
recorded. Additionally, a high positive correlation 
between δ-ALA acid and CP, and the years of 
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